Lipid nanoparticles for mRNA delivery
2021 · Nature Reviews Materials · 3,213 citations
https://doi.org/10.1038/s41578-021-00358-0
T
Tal Zaks
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
101
Papers
10.4K
Citations
32
h-index
48
i10-index
Tal Zaks is an academic researcher from Moderna Therapeutics (United States). The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Genomic variations and chromosomal abnormalities & Gene expression and cancer classification. The author has an h-index of 32, co-authored 86 publications.
Papers by this author
worksPreclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
2017 · Molecular Therapy · 649 citations
https://doi.org/10.1016/j.ymthe.2017.03.035
Immunization with a peptide epitope (p369-377) from HER-2/neu leads to peptide-specific cytotoxic T lymphocytes that fail to recognize HER-2/neu+ tumors.
1998 · PubMed · 219 citations
Phase II Study of Predictive Biomarker Profiles for Response Targeting Human Epidermal Growth Factor Receptor 2 (HER-2) in Advanced Inflammatory Breast Cancer With Lapatinib Monotherapy
2008 · Journal of Clinical Oncology · 194 citations
https://doi.org/10.1200/jco.2007.13.9949
A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus
2021 · Nature Medicine · 165 citations
https://doi.org/10.1038/s41591-021-01573-6
Fas-Mediated Suicide of Tumor-Reactive T Cells Following Activation by Specific Tumor: Selective Rescue by Caspase Inhibition
1999 · The Journal of Immunology · 123 citations
https://doi.org/10.4049/jimmunol.162.6.3273
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat